Atom enrolls first patient in global phase 2 trial of ABP-745 for acute gout flares
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
Prior to this appointment, he served as Vice-Chancellor of Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur,
Late-breaking data presented at WCLC highlight significant and sustained improvements in overall survival, including more than doubling five-year survival rates compared to chemotherapy alone
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Advent acquired Zentiva from Sanofi in 2018 and transformed the company into a highly successful standalone business
Element5’s Agentic AI platform will be integrated with the HCHB EHR
The discussions are expected to pave the way for the creation of a consolidated national knowledge-sharing platform on IT-enabled Ayush services,
The FDA is beginning rulemaking to close the “adequate provision” loophole
Cagrilintide represents a novel approach to obesity management
The study further confirmed that GAL-101 effectively crosses the blood-brain barrier
Subscribe To Our Newsletter & Stay Updated